FDA to allow labs to use coronavirus tests prior to review

The US Food and Drug Administration (FDA) on Saturday said it will allow some laboratories to immediately use tests they have developed and validated to achieve more rapid testing capacity for the coronavirus in the country. Picture: AP

The US Food and Drug Administration (FDA) on Saturday said it will allow some laboratories to immediately use tests they have developed and validated to achieve more rapid testing capacity for the coronavirus in the country. Picture: AP

Published Feb 29, 2020

Share

Washington - The US Food and Drug Administration

(FDA) on Saturday said it will allow some laboratories to

immediately use tests they have developed and validated to

achieve more rapid testing capacity for the coronavirus in the

country.

The policy cleared the way for state public health labs to

immediately begin local testing and possibly get results within

hours, which public health officials say will be critical to a

rapid response to the fast-spreading virus that originated in

China.

"Under this policy, we expect certain laboratories who

develop validated tests for coronavirus would begin using them

right away prior to FDA review," Jeff Shuren, the director of

the FDA's Centre for Devices and Radiological Health, said in a

statement.

The World Health Organisation on Friday said the virus,

which causes a sometimes fatal respiratory illness and has

spread to 46 countries, poses a "very high risk" at a global

level.

On Saturday, New York Governor Andrew Cuomo said his state

would immediately begin using its own test kit developed

in-state. The state's Department of Health on Friday filed an

emergency application with the FDA to request permission to do

so.

"We just received word that our test has been approved by

the FDA. New York State will begin testing immediately at

Wadsworth Lab," the governor said in a statement, referring to

the state's lab in Albany.

New York's public health lab was the first in the country to

seek emergency authorization from the FDA to use its own testing

kits after health officials said faulty tests from the federal

government left them unable to diagnose people quickly in New

York City, the nation's most populous city.

There are 62 confirmed cases of the new coronavirus in the

United States. Most of the people infected fell sick while

abroad and before they were repatriated. No cases have been

detected in New York City, but Mayor Bill de Blasio and health

officials have said its arrival in the city is inevitable.

The weeks-long struggle to expand local testing has been

criticized as an early misstep in the response by US President

Donald Trump's administration to the outbreak.

Trump, who earlier this week described the risk from the

coronavirus as "very low" in the United States, said on Twitter

he will hold a White House press conference about the virus at

1:30pm EST (18:30 GMT) on Saturday.

Three weeks ago, the FDA gave the green light for state and

local labs to start using a testing kit developed by the US Centres for Disease Control and Prevention (CDC).

But most labs that received the kits complained they had

faulty components and produced inconclusive results, which the

CDC later acknowledged.

Meanwhile, the CDC has been working to manufacture new kits

that produce more reliable results.

In a hearing before the US House of Representatives Ways

and Means Committee on Thursday, Health and Human Services (HHS)

Secretary Alex Azar said a newly manufactured CDC test could be

sent to 93 public health labs as soon as Monday.

Reuters

Related Topics:

#coronavirus